MedPath

ReActiv8 Post Market Surveillance Registry

Completed
Conditions
Chronic Low Back Pain
Registration Number
NCT03255200
Lead Sponsor
Mainstay Medical
Brief Summary

To gather data on the long-term safety of ReActiv8 and identify any residual risks by reporting all Serious Adverse Device Effects as well as performance and health care utilization through two years post-implant.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  1. Meet the Indications for ReActiv8
  2. Willing to sign the Informed Consent for the Registry
  3. Age ≥ 18 years
Exclusion Criteria
  1. Subjects will be excluded from the Registry if they are contraindicated for ReActiv8.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Low Back Pain - Numeric Pain Rating (NRS) Scale90 days, 180 days, 1 year, 2 years post Activation

Change in low back pain Numerical Rating Scale (NRS) compared to Baseline. The NRS is an 11-point scale where 0 means no pain at all and 10 means worst imaginable pain. Patients were asked to rate their average low back pain in the last 24 hours. Lower scores or reduction in score means an improvement or reduction in pain.

Secondary Outcome Measures
NameTimeMethod
Serious Adverse Device EffectsThrough 2 years post Activation

All serious device- or procedure-related adverse events.

Trial Locations

Locations (5)

Katholisches Klinikum Koblenz

🇩🇪

Koblenz, Germany

Orthopadisches Krankenhaus Schloss Werneck

🇩🇪

Werneck, Balthasar-Neumann, Germany

Klinikum Magdeburg

🇩🇪

Magdeburg, Germany

Medizinisches Versorgungszentrum Steinburg gGmbH

🇩🇪

Itzehoe, Germany

BG Klinikum Bergmannstrost

🇩🇪

Halle, Germany

© Copyright 2025. All Rights Reserved by MedPath